SCHEMBL19794433

SCHEMBL19794433

c1ccc(-c2ccc(-c3ccccc3-c3cc(-c4ccccc4-c4ccc(-c5ccc6c(c5)oc5ccccc56)nc4)cc(-c4ccccc4-c4ccc(-c5ccc6c(c5)oc5ccccc56)nc4)c3)cn2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
AHR P35869 2/20 0.39
HDAC6 Q9UBN7 1/20 0.38
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
ALOX5 P09917 1/20 0.37
DYRK1A Q13627 1/20 0.37
LDHA P00338 1/20 0.37
HPGDS O60760 2/20 0.37
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
HCRTR1 O43613 1/20 0.36
TTR P02766 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19794373 0.96 AHR (0.41) HSD17B1HSD17B2AHRMMP12MMP13
SCHEMBL21662179 0.92 HDAC6 (0.41) HSD17B1HSD17B2AHRHDAC6MEN1
SCHEMBL23956259 0.91 ALOX5 (0.34) HSD17B1HSD17B2AHRHDAC6MMP12
SCHEMBL18015500 0.88 PDK2 (0.33) HSD17B1HSD17B2AHRHDAC6MMP12
SCHEMBL18015535 0.88 HSP90AA1 (0.43) HSD17B1HSD17B2AHRHDAC6MEN1
SCHEMBL19794442 0.87 IDO1 (0.38) HSD17B1HSD17B2HDAC6MEN1KMT2A
SCHEMBL19933658 0.86 HSP90AA1 (0.40) HSD17B1HSD17B2AHRHDAC6MEN1
SCHEMBL23956263 0.86 HSD17B1 (0.40) HSD17B1HSD17B2HDAC6MMP12MMP13
SCHEMBL20176754 0.84 AHR (0.41) HSD17B1HSD17B2AHRHDAC6MMP12
SCHEMBL21662180 0.84 NPC1 (0.38) HSD17B1HSD17B2HDAC6MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC HSD17B1 4860/4885HSD17B2 4834/4885AHR 3350/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 HSD17B1 4527/4885HSD17B2 4245/4885AHR 2682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.